Business
Politics
Stocks
Investing

Business
Politics
Stocks
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

Operational Update

next post

Mali Court Adjourns Barrick’s Gold Complex Hearing Over Deepening Taxes, Control Dispute

Related Posts

US Capital Global Facilitates $50MM Financing to Accelerate...

June 7, 2025

Tech 5: US Government Strikes Big Tech Deal,...

August 17, 2025

Questcorp Mining Engages Marketing Consulting Firm Spark Newswire

July 2, 2025

Stallion Uranium Completes First Tranche of Non-Brokered Private...

August 21, 2025

Michael Kott Acquires Common Shares of Pinnacle Silver...

July 16, 2025

Top 5 Canadian Lithium Stocks of 2025

July 30, 2025

Element79 Gold Corp Announces Corporate Update and Strategic...

August 16, 2025

Top 5 Canadian Mining Stocks This Week: Avanti...

July 12, 2025

Horizon Minerals

August 22, 2025

Crypto Market Update: GENIUS Act Becomes First Federal...

July 21, 2025

Recent

Pastor recalls last moments with Charlie Kirk: ‘American martyr’
Ryan Routh chastised during opening statements in federal trial for ‘making a mockery’ of the court
Israel’s strike in Qatar triggers rare US rebuke, tests Trump’s Gulf diplomacy
Secret Service under pressure: What Kirk’s assassination means for Trump’s security
What is a bolt action rifle? What we know about the gun used to kill Charlie Kirk
Senate GOP hurtles toward nuclear option after deal with Dems falls apart

Categories

Business (157)
Investing (748)
Politics (859)
Stocks (119)

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 redwoodinvestreport.com | All Rights Reserved